Social value of a set of proposals for the ideal approach of multiple sclerosis within the Spanish National Health System: a social return on investment study

Autor: Ester Moral Torres, Óscar Fernández Fernández, Pedro Carrascal Rueda, Elena Ruiz-Beato, Elvira Estella Pérez, Rita Manzanares Estrada, Teresa Gómez-García, Margarita Jiménez, Álvaro Hidalgo-Vega, María Merino

Publikováno v: BMC Health Services Research, Vol 20, Iss 1, Pp 1-16 (2020)

Abstract Background Multiple Sclerosis (MS) is a chronic inflammatory, demyelinating and neurodegenerative disease that in many cases produces disability, having a high impact in patients’ lives, reducing significantly their quality of life. The ai

Externí odkaz: https://doaj.org/article/f02ef5ac799440668bd5de108e52aff9

The evolution of multiple sclerosis in Spain over the last decade from the patient's perspective

Autor: Diana Monge-Martín, Óscar Fernández-Fernández, Pedro Carrascal-Rueda, Ester Moral-Torres, Francisco J. Campos-Lucas, Fernando Caballero-Martínez

Publikováno v: Multiple sclerosis and related disorders. 57

Background : Updated information about self-reported experience and satisfaction with care of MS patients (PwMS) in Spain is scarce. We aim to describe, from PwMS’ perspective, the disease impact, the quality of life and the satisfaction level with

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::84f373720dbb3cd6de160f58c6a9cbf2
https://pubmed.ncbi.nlm.nih.gov/35158463

Patient experience and self-perceived biopsychosocial burden of people living with multiple sclerosis: An epidemiological survey (BPS-MuScle study) in Spain

Autor: Fernando Caballero-Martínez, Ester Moral-Torres, Diana Monge-Martín, Óscar Fernández-Fernández, Pedro Carrascal-Rueda, Francisco J. Campos-Lucas

Publikováno v: Multiple Sclerosis and Related Disorders. 56:103186

Background Updated information on the self-perceived biopsychosocial burden and the healthcare experience among people living with multiple sclerosis in Spain is scarce.We aim to describe the self-reported disease experience of patients diagnosed wit

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eaacd3e52430b32fc372549c3895aaf2
https://doi.org/10.1016/j.msard.2021.103186

Brief Neuropsychological Battery for multiple sclerosis. Normative data stratified by age and educational level

Autor: Pablo Duque San Juan, Javier Oltra Cucarella, Óscar Fernández Fernández, Jorge Sepulcre Bernard, Grupo de Estudio de la Batería Neu Grupo de Estudio de la Batería Neu

Introducción. La interpretación del rendimiento en los tests cognitivos utilizados en la evaluación neuropsicológica de pacientes con esclerosis múltiple difiere en función del nivel educativo del evaluado. Objetivos. Aportar datos normativos d

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::51fa6523fee6742eff9c88b980458fe9
https://hdl.handle.net/10045/74389

Alemtuzumab for patients with relapsing multiple sclerosis after disease-modifying therapy: a randomised controlled phase 3 trial

Autor: Coles, Alasdair J., Twyman, Cary L., Arnold, Douglas L., Cohen, Jeffrey A., Christian, Confavreux, Fox, Edward J., Hans Peter Hartung, Eva, Havrdova, Selmaj, Krzysztof W., Weiner, Howard L., Tamara, Miller, Elizabeth, Fisher, Rupert, Sandbrink, Lake, Stephen L., Margolin, David H., Pedro, Oyuela, Panzara, Michael A., Compston, D Alastair S., Gupta, the CARE MS II investigators: Ajay S., Edward, Fox, Glyman, Steven A., Thoits, Timothy K., Sullivan, Herman C., Cascione, Mark C., Rammohan, Kottil W., Gazda, Suzanne K., Wynn, Daniel R., Wray, Sibyl E., Stanton, Elias, Ford, Corey C., Andrew, Goodman, Hughes, Bruce L., Omar Azhar Khan, Vaishnav, Anand G., Stephen, Kirzinger, Lynch, Sharon G., Mattson, David H., Braley, Tiffany J., Mikol, Daniel D., Stephen, Krieger, Tamara Ann Miller, Riskind, Peter N., Roberto, Bomprezzi, Wingerchuk, Dean M., Brian, Steingo, Jeffrey Alan Cohen, Crayton, Heidi J., Cooper, Joanna A., Weiner, Leslie P., Harold Moses, J. r., Agius, Mark A., Ann Doan Do Bass, Lallana, Enrico C., Mitchell, Galen W., Krolczyk, Stanley J., Alireza, Minagar, Burk, Jubelt, Evans, Bradley K., Hunter, Samuel F., Rizvi, Syed A., Sheppard, Christopher A., David Honeycutt, W. M., Joseph, Herbert, Lathi, Ellen S., Gabriel, Pardo, Lily Jung Ilenson, Rothstein, Ted L., Thrower, Ben W., Mary Ann Picone, Mariko, Kita, Grazioli, Erica M., Silliman, Scott L., Thomas, Giancarlo, Gottesman, Malcolm H., Abou Zeid, Nuhad E., Rowe, Vernon D., Boutwell, Christine M., Schaeffer, John D., Riley, Claire S., Edwards, Keith R., Wendt, Jeanette K., G. Kim Bigley J. r., Shubin, Richard A., Silva Markovic Plese, Jones, Davis E., Gary, Clauser, Freedman, Mark S., Francois, Grand’Maison, Jacques, Francois H., Traboulsee, Anthony L., Brunet, Donald G., Marcelo, Kremenchutzky, Charles, Ayotte, Lava, Neil S., Waldman, Stephen R., Janus, Todd J., Stephen Gerard Vincent, Mark, Gudesblatt, Michael, Rossen, Stein, Lee S., Bennett Irving Machanic, Timothy, Vollmer, Gitt, Jeffrey S., Jeffrey, Dunn, Donald, Negroski, Fletcher, Mark H., Adil, Javed, Frohman, Elliot M., Richard, Macdonell, John Owen King, Paine, Mark A., Karyn, Boundy, Simon, Broadley, Steve, Vucic, Stephen, Reddel, Dreyer, Michael D., Raymond, Schwartz, Pamela Ann McCombe, Suzanne, Hodgkinson, Charles, Tilbery, Ferreira, Maria Lucia B., Dagoberto, Callegaro, Marcio Mena Barreto Martins, Jesus Arturo Violante Villanueva, Noemi Santos Caballero, Claudia Venzor Mendoza, Norma Haydee Deri, Alasdair, Coles, Neil James Scolding, Gavin, Giovannoni, Basil, Sharrack, Rog, David J., Giancarlo, Comi, Angelo, Ghezzi, Mancardi, Giovanni L., Durelli, Luca, Antonio, Bertolotto, Ruggero, Capra, Carlo, Pozzilli, Maria Giovanna Marrosu, Hupperts, Raymond M. M., Erik van Munster, Xavier, Montalbán, Rafael Arroyo González, Guillermo Izquierdo Ayuso, Óscar Fernández Fernández, Patrick, Vermersch, Jerome de Seze, Thibault, Moreau, Pierre, Clavelou, Catherine, Lubetzki, Michel, Clanet, Marc, Debouverie, Gilles, Edan, Judith, Haas, Martin, Stangel, Tjalf, Ziemssen, Bernhard, Hemmer, Karl, Baum, Klaus Zettl, U., Herrlinger, U., Wolfgang, Köhler, Gunter, Ochs, Patrick, Oschmann, Klaus Tiel Wilck, Hayrettin, Tumani, Urban, Peter P., Jan, Lycke, Anders, Svenningsson, Ivana, Kovarova, Marta, Vachova, Ivan, Rektor, Radomir, Talab, Krzysztof, Selmaj, Zbigniew, Stelmasiak, Wojciech, Kozubski, Dubois, Benedicte D. P., Dominique, Dive, Christian, Sindic, Karl, Vass, Per Soelberg Sørensen, Thor, Petersen, Mads, Ravnborg, Anat, Achiron, Adi Vaknin Dembinsky, Arnon, Karni, Gusev, Evgeny I., Stolyarov, Igor D., Zavalishin, Igor A., Skoromets, Alexander A., Boyko, Alexei N., Belova, Anna N., Malkova, Nadezhda A., Barantsevich, Evgeniy R., Yakupov, Eduard Z., Perfiliev, Semen V., Poverennova, Irina E., Voloshyna, Natalia P., Nehrych, Tetyana I., Kobys, Tetyana O., Mario, Habek, Vesna, Brinar, Zlatko, Trkanjec, Anton, Vladić, Spomenka Kidemet Piskać, Licia, Antonelli, Jelena, Drulović, Čongor, Nadj, Evica, Dinčić, Gordana, Tončev

Publikováno v: Lancet, Vol. 380, no.9856, p. 1829-39 (2012)
Lancet, 380(9856), 1829-1839. Elsevier Science
Coles, A J, Twyman, C L, Arnold, D L, Cohen, J A, Confavreux, C, Fox, E J, Hartung, H P, Havrdova, E, Selmaj, K W, Weiner, H L, Miller, T, Fisher, E, Sandbrink, R, Lake, S L, Margolin, D H, Oyuela, P, Barkhof, F, Panzara, M A & Compston, D 2012, ' Alemtuzumab for patients with relapsing multiple sclerosis after disease-modifying therapy: a randomised controlled phase 3 trial ', Lancet, vol. 380, no. 9856, pp. 1829-1839 . https://doi.org/10.1016/S0140-6736(12)61768-1
Lancet, 380(9856), 1829-1839. Elsevier Limited

The anti-CD52 monoclonal antibody alemtuzumab reduces disease activity in previously untreated patients with relapsing-remitting multiple sclerosis. We aimed to assess efficacy and safety of alemtuzumab compared with interferon beta 1a in patients wh

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5343ccdf870f53b162ad834320ab3bfe
https://doi.org/10.1016/s0140-6736(12)61768-1